Principal Securities’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5
Closed -$176 1503
2025
Q3
$176 Sell
5
-8
-62% -$276 ﹤0.01% 3659
2025
Q2
$426 Sell
13
-473
-97% -$15.4K ﹤0.01% 3506
2025
Q1
$14.9K Hold
486
﹤0.01% 2358
2024
Q4
$14.9K Sell
486
-213
-30% -$6.85K ﹤0.01% 2354
2024
Q3
$19.6K Buy
699
+120
+21% +$2.96K ﹤0.01% 2134
2024
Q2
$13.2K Buy
579
+132
+30% +$3.05K ﹤0.01% 2268
2024
Q1
$13.6K Buy
447
+61
+16% +$2.04K ﹤0.01% 2194
2023
Q4
$13.8K Buy
+386
New +$14.4K ﹤0.01% 2106

Other funds holding ATRC

Principal Securities's ATRC Position: Q4 2025 in Review

Principal Securities sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 5 shares — an estimated $176 sold.

Principal Securities first reported a position in ATRC in Q4 2023 and held it in 8 quarters. The position peaked at $19.6K in Q3 2024. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Principal Securities reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 5 AtriCure shares in Q4 2025, an estimated $176.
  • Principal Securities first reported a position in AtriCure in Q4 2023 and held it in 8 quarters.
  • Principal Securities's AtriCure position peaked at $19.6K in Q3 2024.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.